TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Supporting Patient Activation in Transition to Home (sPATH) Intervention - a Study Protocol of Randomized Controlled Trial
Brief Summary: This study evaluates if motivational interviewing sessions aiming to motivate recently discharged patients with either chronic obstructive pulmonary disease or congestive heart failure to be active in post-discharge self-management can reduce re-hospitalization rates.


Options:
A: Arm Label: Psychoeducative intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducative intervention | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychoeducative intervention; Assigned to Arm(s): Psychoeducative intervention
B: Arm Label: Disease management program; Type: EXPERIMENTAL; Interventions: Other: Disease Management | Arm Label: Usual site management; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual site management | Intervention Type: OTHER; Name: Disease Management; Assigned to Arm(s): Disease management program | Intervention Type: OTHER; Name: Usual site management; Assigned to Arm(s): Usual site management
C: Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Device: Electrostimulation | Arm Label: Sham ES; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham stimulation | Intervention Type: DEVICE; Name: Electrostimulation; Assigned to Arm(s): ES | Intervention Type: DEVICE; Name: Sham stimulation; Assigned to Arm(s): Sham ES
D: Arm Label: sPATH; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): sPATH

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Supporting Patient Activation in Transition to Home (sPATH) Intervention - a Study Protocol of Randomized Controlled Trial
Brief Summary: This study evaluates if motivational interviewing sessions aiming to motivate recently discharged patients with either chronic obstructive pulmonary disease or congestive heart failure to be active in post-discharge self-management can reduce re-hospitalization rates.


Options:
A: Arm Label: COPD subjects; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Non-smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Intervention Type: OTHER; Name: Novel endpoint determination; Assigned to Arm(s): COPD subjects, Non-smoker controls, Smoker controls
B: Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Device: telemedicine program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: telemedicine program; Assigned to Arm(s): Telemedicine
C: Arm Label: Tool + Self-management Support Program; Type: EXPERIMENTAL; Interventions: Device: Tool, Behavioral: Self-management Support Program | Arm Label: Self- management Support Program; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management Support Program | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Tool; Assigned to Arm(s): Tool + Self-management Support Program | Intervention Type: BEHAVIORAL; Name: Self-management Support Program; Assigned to Arm(s): Self- management Support Program, Tool + Self-management Support Program
D: Arm Label: sPATH; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): sPATH

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mid-term Effect of a Novel Sit-to-stand Workplace (ACTIVE OFFICE) on Cognitive and Physiological Parameters
Brief Summary: Prolonged sitting is a risk factor for cardiovascular and musculoskeletal diseases, diabetes, several types of cancer and all-cause mortality. In combination with static and awkward postures, the prevalence of musculoskeletal diseases can increase further. Although the implementation of sit-to-stand or active workstations can help to reduce sitting time, improve physical activity at work and promote health benefits, it might also lead to changes in cognitive functions such as productivity The purpose of this study is to evaluate the mid-term effect of a novel two desk sit-to-stand workplace on sitting time as well as physiological and cognitive parameters for healthy people of working age in comparison to their traditional workplace.


Options:
A: Arm Label: Control condition; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Physical Activity Coaching; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity coaching | Intervention Type: BEHAVIORAL; Name: physical activity coaching; Assigned to Arm(s): Physical Activity Coaching
B: Arm Label: multi-component intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Sit-stand workstation provision | Arm Label: Sit-stand workstation only; Type: EXPERIMENTAL; Interventions: Behavioral: Sit-stand workstation provision | Arm Label: Usual practice (seated workstation); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Sit-stand workstation provision; Assigned to Arm(s): Sit-stand workstation only, multi-component intervention
C: Arm Label: Novel workplace - first half; Type: EXPERIMENTAL; Interventions: Other: Workplace consisting of two height-adjustable desks | Arm Label: Novel workplace - second half; Type: EXPERIMENTAL; Interventions: Other: Workplace consisting of two height-adjustable desks | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Workplace consisting of two height-adjustable desks; Assigned to Arm(s): Novel workplace - first half, Novel workplace - second half
D: Arm Label: Lifestyle change; Type: EXPERIMENTAL; Interventions: Behavioral: Reduction of sedentary time by breaking it with low intensity physical activity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Reduction of sedentary time by breaking it with low intensity physical activity; Assigned to Arm(s): Lifestyle change

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mid-term Effect of a Novel Sit-to-stand Workplace (ACTIVE OFFICE) on Cognitive and Physiological Parameters
Brief Summary: Prolonged sitting is a risk factor for cardiovascular and musculoskeletal diseases, diabetes, several types of cancer and all-cause mortality. In combination with static and awkward postures, the prevalence of musculoskeletal diseases can increase further. Although the implementation of sit-to-stand or active workstations can help to reduce sitting time, improve physical activity at work and promote health benefits, it might also lead to changes in cognitive functions such as productivity The purpose of this study is to evaluate the mid-term effect of a novel two desk sit-to-stand workplace on sitting time as well as physiological and cognitive parameters for healthy people of working age in comparison to their traditional workplace.


Options:
A: Arm Label: Reference; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health check only | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity and Health check | Intervention Type: BEHAVIORAL; Name: Physical activity and Health check; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Health check only; Assigned to Arm(s): Reference
B: Arm Label: Steps to Health; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Steps to Health | Arm Label: Steps to Health Plus!; Type: EXPERIMENTAL; Interventions: Behavioral: Steps to Health Plus! | Arm Label: Observational Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Steps to Health; Assigned to Arm(s): Steps to Health | Intervention Type: BEHAVIORAL; Name: Steps to Health Plus!; Assigned to Arm(s): Steps to Health Plus!
C: Arm Label: Novel workplace - first half; Type: EXPERIMENTAL; Interventions: Other: Workplace consisting of two height-adjustable desks | Arm Label: Novel workplace - second half; Type: EXPERIMENTAL; Interventions: Other: Workplace consisting of two height-adjustable desks | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Workplace consisting of two height-adjustable desks; Assigned to Arm(s): Novel workplace - first half, Novel workplace - second half
D: Arm Label: Worksite Environmental Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: weight gain prevention | Arm Label: No-contact control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: weight gain prevention; Assigned to Arm(s): Worksite Environmental Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Conventional and Ultrasound Guided Techniques of Radial Artery Cannulation in Different Hemodynamic Subsets: a Randomized Controlled Study
Brief Summary: Purpose Two techniques of radial artery cannulation, ultrasound guided (USG) and conventional method (CM) were compared to find the better technique in general and in different hemodynamic subsets of patients.

Method This is a prospective randomized, single center study of 100 patients. The details of the primary cannulation technique, number of attempts, time taken, failure and cross-over technique were recorded for three different hemodynamic subsets with Systolic blood pressure \<80 mm hg, 80-100 mm hg and \> 100 mm hg.


Options:
A: Arm Label: Conventional method (CM); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial artery cannulation | Arm Label: Ultrasound guided method (USG); Type: EXPERIMENTAL; Interventions: Procedure: Radial artery cannulation | Intervention Type: PROCEDURE; Name: Radial artery cannulation; Assigned to Arm(s): Conventional method (CM), Ultrasound guided method (USG)
B: Arm Label: Palpation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Palpation | Arm Label: Ultrasound; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guidance | Intervention Type: PROCEDURE; Name: Ultrasound guidance; Assigned to Arm(s): Ultrasound | Intervention Type: PROCEDURE; Name: Palpation; Assigned to Arm(s): Palpation
C: Arm Label: Distal radial artery access; Type: EXPERIMENTAL; Interventions: Procedure: Distal radial artery access | Arm Label: Proximal radial artery access; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Proximal radial artery surgery | Intervention Type: PROCEDURE; Name: Distal radial artery access; Assigned to Arm(s): Distal radial artery access | Intervention Type: PROCEDURE; Name: Proximal radial artery surgery; Assigned to Arm(s): Proximal radial artery access
D: Arm Label: Radial access; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial Access | Arm Label: State-of-the-art femoral access; Type: ACTIVE_COMPARATOR; Interventions: Procedure: State-of-the-art femoral access with 18 gauge needle, Procedure: State-of-the-art femoral access with 21 gauge needle | Intervention Type: PROCEDURE; Name: Radial Access; Assigned to Arm(s): Radial access | Intervention Type: PROCEDURE; Name: State-of-the-art femoral access with 18 gauge needle; Assigned to Arm(s): State-of-the-art femoral access | Intervention Type: PROCEDURE; Name: State-of-the-art femoral access with 21 gauge needle; Assigned to Arm(s): State-of-the-art femoral access

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Conventional and Ultrasound Guided Techniques of Radial Artery Cannulation in Different Hemodynamic Subsets: a Randomized Controlled Study
Brief Summary: Purpose Two techniques of radial artery cannulation, ultrasound guided (USG) and conventional method (CM) were compared to find the better technique in general and in different hemodynamic subsets of patients.

Method This is a prospective randomized, single center study of 100 patients. The details of the primary cannulation technique, number of attempts, time taken, failure and cross-over technique were recorded for three different hemodynamic subsets with Systolic blood pressure \<80 mm hg, 80-100 mm hg and \> 100 mm hg.


Options:
A: Arm Label: Ultrasound group; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound -guided cannulation | Arm Label: Palpation group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Palpation -guided cannulation | Intervention Type: PROCEDURE; Name: Ultrasound -guided cannulation; Assigned to Arm(s): Ultrasound group | Intervention Type: PROCEDURE; Name: Palpation -guided cannulation; Assigned to Arm(s): Palpation group
B: Arm Label: Conventional method (CM); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial artery cannulation | Arm Label: Ultrasound guided method (USG); Type: EXPERIMENTAL; Interventions: Procedure: Radial artery cannulation | Intervention Type: PROCEDURE; Name: Radial artery cannulation; Assigned to Arm(s): Conventional method (CM), Ultrasound guided method (USG)
C: Arm Label: The first group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: The radial artery cannulation over 2 cm of the wrist | Arm Label: The second group; Type: EXPERIMENTAL; Interventions: Procedure: The radial artery cannulation in the distal 3/4 area of the forearm | Arm Label: The third group; Type: EXPERIMENTAL; Interventions: Procedure: The radial artery cannulation in the distal 1/2 area of the forearm | Intervention Type: PROCEDURE; Name: The radial artery cannulation over 2 cm of the wrist; Assigned to Arm(s): The first group | Intervention Type: PROCEDURE; Name: The radial artery cannulation in the distal 3/4 area of the forearm; Assigned to Arm(s): The second group | Intervention Type: PROCEDURE; Name: The radial artery cannulation in the distal 1/2 area of the forearm; Assigned to Arm(s): The third group
D: Arm Label: Palpation only; Type: ACTIVE_COMPARATOR; Interventions: Procedure: RAP palpation only | Arm Label: Ultrasound guidance; Type: EXPERIMENTAL; Interventions: Procedure: RAP with ultrasound guidance | Intervention Type: PROCEDURE; Name: RAP palpation only; Assigned to Arm(s): Palpation only | Intervention Type: PROCEDURE; Name: RAP with ultrasound guidance; Assigned to Arm(s): Ultrasound guidance

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Conventional and Ultrasound Guided Techniques of Radial Artery Cannulation in Different Hemodynamic Subsets: a Randomized Controlled Study
Brief Summary: Purpose Two techniques of radial artery cannulation, ultrasound guided (USG) and conventional method (CM) were compared to find the better technique in general and in different hemodynamic subsets of patients.

Method This is a prospective randomized, single center study of 100 patients. The details of the primary cannulation technique, number of attempts, time taken, failure and cross-over technique were recorded for three different hemodynamic subsets with Systolic blood pressure \<80 mm hg, 80-100 mm hg and \> 100 mm hg.


Options:
A: Arm Label: Conventional method (CM); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial artery cannulation | Arm Label: Ultrasound guided method (USG); Type: EXPERIMENTAL; Interventions: Procedure: Radial artery cannulation | Intervention Type: PROCEDURE; Name: Radial artery cannulation; Assigned to Arm(s): Conventional method (CM), Ultrasound guided method (USG)
B: Arm Label: Palpation only; Type: ACTIVE_COMPARATOR; Interventions: Procedure: RAP palpation only | Arm Label: Ultrasound guidance; Type: EXPERIMENTAL; Interventions: Procedure: RAP with ultrasound guidance | Intervention Type: PROCEDURE; Name: RAP palpation only; Assigned to Arm(s): Palpation only | Intervention Type: PROCEDURE; Name: RAP with ultrasound guidance; Assigned to Arm(s): Ultrasound guidance
C: Arm Label: Fluoroscopic + Ultrasound Guidance; Type: EXPERIMENTAL; Interventions: Procedure: Fluoroscopic + Ultrasound Guidance | Arm Label: Fluoroscopic Guidance Alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Fluoroscopic + Ultrasound Guidance; Assigned to Arm(s): Fluoroscopic + Ultrasound Guidance
D: Arm Label: Oblique; Type: EXPERIMENTAL; Interventions: Procedure: radial artery Catheterization | Arm Label: Transverse group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Arm Label: Longitudinal group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Intervention Type: PROCEDURE; Name: radial artery Catheterization; Assigned to Arm(s): Longitudinal group, Oblique, Transverse group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Swallowing Function, Oral Health, and Food Intake in Old Age
Brief Summary: The purpose of this study is to determine whether a specific rehabilitation program with oral screen used in an elderly population with dysphagia can improve elderly's swallowing capacity.


Options:
A: Arm Label: OHI; Type: EXPERIMENTAL; Interventions: Other: Oral hygiene intervention | Arm Label: OHI + CHX mouthrinse; Type: EXPERIMENTAL; Interventions: Other: Oral hygiene intervention | Arm Label: OHI + CHX mouthrinse + assisted brushing; Type: EXPERIMENTAL; Interventions: Other: Oral hygiene intervention | Intervention Type: OTHER; Name: Oral hygiene intervention; Assigned to Arm(s): OHI, OHI + CHX mouthrinse, OHI + CHX mouthrinse + assisted brushing
B: Arm Label: enhanced oral care; Type: EXPERIMENTAL; Interventions: Other: Enhanced Oral Care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual oral care | Intervention Type: OTHER; Name: Enhanced Oral Care; Assigned to Arm(s): enhanced oral care | Intervention Type: OTHER; Name: Usual oral care; Assigned to Arm(s): Usual care
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Oral screen | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Oral screen; Assigned to Arm(s): Intervention group
D: Arm Label: Enhanced complex oral health care intervention; Type: EXPERIMENTAL; Interventions: Other: Enhanced complex oral health care | Arm Label: Usual oral health care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Enhanced complex oral health care; Assigned to Arm(s): Enhanced complex oral health care intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vaginal Hysterectomy Versus Laparoscopically Assisted Hysterectomy for Large Uteri ( A Pilot Randomized Clinical Trial)
Brief Summary: The investigators compare between Vaginal Hysterectomy and Laparoscopically assisted vaginal hysterectomy in cases of large uteri weighing more than 280 gm regarding operative and Postoperative outcomes


Options:
A: Arm Label: Robot assisted laparoscopic hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot assisted laparoscopic hysterectomy | Arm Label: Abdominal hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Abdominal hysterectomy; Assigned to Arm(s): Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Robot assisted laparoscopic hysterectomy; Assigned to Arm(s): Robot assisted laparoscopic hysterectomy
B: Arm Label: VH; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Vaginal hysterectomy | Arm Label: LAVH; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic assisted vaginal hysterectomy | Intervention Type: PROCEDURE; Name: Vaginal hysterectomy; Assigned to Arm(s): VH | Intervention Type: PROCEDURE; Name: Laparoscopic assisted vaginal hysterectomy; Assigned to Arm(s): LAVH
C: Arm Label: single-port LAVH; Type: EXPERIMENTAL; Interventions: Procedure: single-port LAVH | Intervention Type: PROCEDURE; Name: single-port LAVH; Assigned to Arm(s): single-port LAVH
D: Arm Label: I; Type: ACTIVE_COMPARATOR; Interventions: Procedure: laparoscopy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: vaginal | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: abdominal | Intervention Type: PROCEDURE; Name: laparoscopy; Assigned to Arm(s): I | Intervention Type: PROCEDURE; Name: vaginal; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: abdominal; Assigned to Arm(s): 3

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 52-week, Randomized, Double-blind Study of Secukinumab (300 mg) Compared to Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis
Brief Summary: Demonstrate superiority of secukinumab over ustekinumab in treatment of moderate to severe plaque psoriasis.


Options:
A: Arm Label: Secukinumab; Type: EXPERIMENTAL; Interventions: Drug: Secukinumab | Arm Label: Ustekinumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ustekinumab | Intervention Type: DRUG; Name: Secukinumab; Assigned to Arm(s): Secukinumab | Intervention Type: DRUG; Name: Ustekinumab; Assigned to Arm(s): Ustekinumab
B: Arm Label: Bimekizumab cohort; Type: EXPERIMENTAL; Interventions: Drug: Bimekizumab, Other: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Bimekizumab Escape arm; Type: EXPERIMENTAL; Interventions: Drug: Bimekizumab | Intervention Type: DRUG; Name: Bimekizumab; Assigned to Arm(s): Bimekizumab Escape arm, Bimekizumab cohort | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Bimekizumab cohort, Placebo
C: Arm Label: Group 1: Approved q12w maintenance regimen; Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab 45 mg, Drug: Ustekinumab 90 mg, Drug: Placebo | Arm Label: Group 2: Subject-tailored fixed-interval maintenance regimen; Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab 45 mg, Drug: Ustekinumab 90 mg, Drug: Placebo | Intervention Type: DRUG; Name: Ustekinumab 45 mg; Assigned to Arm(s): Group 1: Approved q12w maintenance regimen, Group 2: Subject-tailored fixed-interval maintenance regimen | Intervention Type: DRUG; Name: Ustekinumab 90 mg; Assigned to Arm(s): Group 1: Approved q12w maintenance regimen, Group 2: Subject-tailored fixed-interval maintenance regimen | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 1: Approved q12w maintenance regimen, Group 2: Subject-tailored fixed-interval maintenance regimen
D: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Etanercept | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Drug: Etanercept + Acitretin | Arm Label: Group C; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acitretin | Intervention Type: DRUG; Name: Etanercept; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: Etanercept + Acitretin; Assigned to Arm(s): Group B | Intervention Type: DRUG; Name: Acitretin; Assigned to Arm(s): Group C

Answer: A